1. Home
  2. HBIO vs GSIW Comparison

HBIO vs GSIW Comparison

Compare HBIO & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

N/A

Current Price

$0.48

Market Cap

25.7M

Sector

Industrials

ML Signal

N/A

GSIW

Garden Stage Limited

N/A

Current Price

$30.45

Market Cap

28.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
HBIO
GSIW
Founded
1901
2016
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
25.7M
28.6M
IPO Year
2000
2022

Fundamental Metrics

Financial Performance
Metric
HBIO
GSIW
Price
$0.48
$30.45
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$2.50
N/A
AVG Volume (30 Days)
377.0K
587.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$116,176,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.80
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.05
52 Week High
$0.95
$9.35

Technical Indicators

Market Signals
Indicator
HBIO
GSIW
Relative Strength Index (RSI) 33.59 99.77
Support Level $0.47 $0.11
Resistance Level $0.55 N/A
Average True Range (ATR) 0.04 1.84
MACD -0.01 2.48
Stochastic Oscillator 6.33 97.95

Price Performance

Historical Comparison
HBIO
GSIW

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

Share on Social Networks: